Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1041200090

Enrollment

150

Registered

2021-01-06

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoprosis osteoprosis

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: primary osteoporosis

Exclusion criteria

Exclusion criteria: 1. Previous romosozumab or denosumab use. 2. hypocalcemia 3. Cardiovascular events within 1 year 4. Pregnant or lactating women, those who wish to become pregnant 5. Patients judg ed to be inappropriate for study

Design outcomes

Primary

Measure	Time frame
Bone density chang e (lumbar spine)	—

Secondary

Measure	Time frame
Bone density(total hip, femoral neck),Bone metabolic marker	—

Contacts

Public ContactTomonori Kobayakawa

Kobayakawa Orthopedic and Rheumatologic clinic

kobatomo0109@yahoo.co.jp+81-538-43-5800

Outcome results